October 11, 2025 • 3 mins
Welcome to Ozempic Weightloss Unlocked, where we explore the latest developments in weight loss medications and their real-world impact.
Let's dive into some groundbreaking research that's challenging assumptions about these medications. Yale economist Jason Abaluck recently completed a major study tracking over 20,000 patients who were prescribed semaglutide, the active ingredient in both Ozempic and Wegovy. While the drugs delivered impressive health improvements including weight loss, blood pressure reduction, and better cholesterol levels, they didn't actually lower overall healthcare costs. In fact, non-semaglutide medical expenses increased during the two years after patients started treatment. This doesn't mean the drugs aren't valuable. Abaluck emphasizes these are miraculous medications that should be widely prescribed, but policymakers need to plan for increased costs rather than expecting immediate savings.
Speaking of these medications, many listeners wonder about the difference between Ozempic and Wegovy. Both contain semaglutide and work by mimicking a natural hormone called glucagon-like peptide-1. They suppress appetite, slow digestion, enhance insulin release, and inhibit glucagon. The key difference is their intended use. Ozempic is approved for type 2 diabetes management and cardiovascular risk reduction, with doses up to 2 milligrams weekly. Wegovy targets chronic weight management in adults with obesity, using higher doses up to 2.4 milligrams weekly. Clinical trials show most patients see substantial results within 4 to 6 months, with full effects typically appearing after one year.
An interesting trend has emerged around microdosing these medications. Some people are taking very small doses hoping for subtle benefits with fewer side effects. However, doctors specializing in weight loss caution that microdosing hasn't been studied enough to guarantee safety or effectiveness. Novo Nordisk, the company behind both drugs, does not condone microdosing and emphasizes that approved doses are the only strengths studied in clinical development programs.
Exciting news on the muscle loss front. University of Alberta researchers discovered that combining semaglutide with ketone supplements can prevent the unwanted side effect of muscle loss. Studies show nearly 40 percent of weight loss from these drugs can come from muscle rather than fat. The research team found that ketone supplements protected both skeletal muscle and heart muscle while maintaining the same fat loss. This could be a game-changer for patients concerned about losing lean muscle mass.
Looking ahead, oral versions of these medications are in development. Two new pills showed promising results in recent clinical trials. One version of oral semaglutide and another drug called orforglipron demonstrated significant weight loss without requiring injections or refrigeration. These pills must be taken daily rather than weekly, but they're easier to manufacture and distribute, potentially making them more accessible and affordable than current injectable options.
Thank you for tuning in to Ozempic Weightloss Unlocked. Don't forget to subscribe for more updates on weight loss medications and health innovations. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
Let's dive into some groundbreaking research that's challenging assumptions about these medications. Yale economist Jason Abaluck recently completed a major study tracking over 20,000 patients who were prescribed semaglutide, the active ingredient in both Ozempic and Wegovy. While the drugs delivered impressive health improvements including weight loss, blood pressure reduction, and better cholesterol levels, they didn't actually lower overall healthcare costs. In fact, non-semaglutide medical expenses increased during the two years after patients started treatment. This doesn't mean the drugs aren't valuable. Abaluck emphasizes these are miraculous medications that should be widely prescribed, but policymakers need to plan for increased costs rather than expecting immediate savings.
Speaking of these medications, many listeners wonder about the difference between Ozempic and Wegovy. Both contain semaglutide and work by mimicking a natural hormone called glucagon-like peptide-1. They suppress appetite, slow digestion, enhance insulin release, and inhibit glucagon. The key difference is their intended use. Ozempic is approved for type 2 diabetes management and cardiovascular risk reduction, with doses up to 2 milligrams weekly. Wegovy targets chronic weight management in adults with obesity, using higher doses up to 2.4 milligrams weekly. Clinical trials show most patients see substantial results within 4 to 6 months, with full effects typically appearing after one year.
An interesting trend has emerged around microdosing these medications. Some people are taking very small doses hoping for subtle benefits with fewer side effects. However, doctors specializing in weight loss caution that microdosing hasn't been studied enough to guarantee safety or effectiveness. Novo Nordisk, the company behind both drugs, does not condone microdosing and emphasizes that approved doses are the only strengths studied in clinical development programs.
Exciting news on the muscle loss front. University of Alberta researchers discovered that combining semaglutide with ketone supplements can prevent the unwanted side effect of muscle loss. Studies show nearly 40 percent of weight loss from these drugs can come from muscle rather than fat. The research team found that ketone supplements protected both skeletal muscle and heart muscle while maintaining the same fat loss. This could be a game-changer for patients concerned about losing lean muscle mass.
Looking ahead, oral versions of these medications are in development. Two new pills showed promising results in recent clinical trials. One version of oral semaglutide and another drug called orforglipron demonstrated significant weight loss without requiring injections or refrigeration. These pills must be taken daily rather than weekly, but they're easier to manufacture and distribute, potentially making them more accessible and affordable than current injectable options.
Thank you for tuning in to Ozempic Weightloss Unlocked. Don't forget to subscribe for more updates on weight loss medications and health innovations. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to Ozepic weight Loss Unlocked, where we explore the
latest developments and weight loss medications and their real world impact.
Let's dive into some groundbreaking research that's challenging assumptions about
these medications. Yale economist Jason Abelock recently completed a major
study tracking over twenty thousand patients who were prescribed semaglutide,
(00:23):
the active ingredient in both ozempic and wegov. While the
drugs delivered impressive health improvements including weight loss, blood pressure reduction,
and better cholesterol levels, they didn't actually lower overall health
care costs. In fact, non semaglutide medical expenses increased during
the two years after patients started treatment. This doesn't mean
(00:44):
the drugs are valuable. Abelok emphasizes these are miraculous medications
that should be widely prescribed, but policymakers need to plan
for increased costs rather than expecting immediate savings. Speaking of
these medications, many listeners wonder about the difference between azepic
and wegov. Both contain semiglutide and work by mimicking a
(01:06):
natural hormone called glucagun Like peptide one, they suppress appetite,
slow digestion, enhance insulin release, and inhibit glucagun The key
difference is their intended use. Ozempic is approved for type
two diabetes management and cardiovascular risk reduction with doses up
to two milligrams weekly. We go vy Target's chronic weight
(01:27):
management in adults with obesity using higher doses up to
two point four milligrams weekly. Clinical trials show most patients
see substantial results within four to six months, with full
effects typically appearing after one year. An interesting trend has
emerged around microdosing these medications. Some people are taking very
small doses, hoping for subtle benefits with fewer side effects. However,
(01:51):
doctors specializing in weight loss caution that microdosing hasn't been
studied enough to guarantee safety or effectiveness. Novo Nordisk, the
company behind both drugs, does not condone microdosing and emphasizes
that approved doses are the only strength studied in clinical
development programs. Exciting news on the muscle loss front, University
(02:11):
of Alberta researchers discovered that combining semaglutide with ketone supplements
can prevent the unwonted side effect of muscle loss front
is caused by muscle fat coder. The muscle coder is
also caused by muscle protein pressure and muscle placed pressure.
The research team found that ketone supplements protected both skeletal
muscle and heart muscle while maintaining the same fat loss.
(02:34):
This could be a game changer for patients concerned about
losing lean muscle mass. Looking ahead, oral versions of these
medications are in development. Two new pills showed promising results
in recent clinical trials. One version of oral semaglutide and
another drug called ore four glipron demonstrated significant weight loss
(02:54):
without requiring injections or refrigeration. These pills must be taken
daily rather than weakly, but they're easier to manufacture and distribute,
potentially making them more accessible and affordable than current injectable options.
Thank you for tuning in to Ozepic weight Loss Unlocked.
Don't forget to subscribe for more updates on weight loss
(03:15):
medications and health innovations. This has been a quiet please production.
For more check out Quiet Please dot ai
Welcome to Ozepic weight Loss Unlocked, where we explore the
latest developments and weight loss medications and their real world impact.
Let's dive into some groundbreaking research that's challenging assumptions about
these medications. Yale economist Jason Abelock recently completed a major
study tracking over twenty thousand patients who were prescribed semaglutide,
(00:23):
the active ingredient in both ozempic and wegov. While the
drugs delivered impressive health improvements including weight loss, blood pressure reduction,
and better cholesterol levels, they didn't actually lower overall health
care costs. In fact, non semaglutide medical expenses increased during
the two years after patients started treatment. This doesn't mean
(00:44):
the drugs are valuable. Abelok emphasizes these are miraculous medications
that should be widely prescribed, but policymakers need to plan
for increased costs rather than expecting immediate savings. Speaking of
these medications, many listeners wonder about the difference between azepic
and wegov. Both contain semiglutide and work by mimicking a
(01:06):
natural hormone called glucagun Like peptide one, they suppress appetite,
slow digestion, enhance insulin release, and inhibit glucagun The key
difference is their intended use. Ozempic is approved for type
two diabetes management and cardiovascular risk reduction with doses up
to two milligrams weekly. We go vy Target's chronic weight
(01:27):
management in adults with obesity using higher doses up to
two point four milligrams weekly. Clinical trials show most patients
see substantial results within four to six months, with full
effects typically appearing after one year. An interesting trend has
emerged around microdosing these medications. Some people are taking very
small doses, hoping for subtle benefits with fewer side effects. However,
(01:51):
doctors specializing in weight loss caution that microdosing hasn't been
studied enough to guarantee safety or effectiveness. Novo Nordisk, the
company behind both drugs, does not condone microdosing and emphasizes
that approved doses are the only strength studied in clinical
development programs. Exciting news on the muscle loss front, University
(02:11):
of Alberta researchers discovered that combining semaglutide with ketone supplements
can prevent the unwonted side effect of muscle loss front
is caused by muscle fat coder. The muscle coder is
also caused by muscle protein pressure and muscle placed pressure.
The research team found that ketone supplements protected both skeletal
muscle and heart muscle while maintaining the same fat loss.
(02:34):
This could be a game changer for patients concerned about
losing lean muscle mass. Looking ahead, oral versions of these
medications are in development. Two new pills showed promising results
in recent clinical trials. One version of oral semaglutide and
another drug called ore four glipron demonstrated significant weight loss
(02:54):
without requiring injections or refrigeration. These pills must be taken
daily rather than weakly, but they're easier to manufacture and distribute,
potentially making them more accessible and affordable than current injectable options.
Thank you for tuning in to Ozepic weight Loss Unlocked.
Don't forget to subscribe for more updates on weight loss
(03:15):
medications and health innovations. This has been a quiet please production.
For more check out Quiet Please dot ai
Popular Podcasts
CrimeLess: Hillbilly Heist
It’s 1996 in rural North Carolina, and an oddball crew makes history when they pull off America’s third largest cash heist. But it’s all downhill from there. Join host Johnny Knoxville as he unspools a wild and woolly tale about a group of regular ‘ol folks who risked it all for a chance at a better life. CrimeLess: Hillbilly Heist answers the question: what would you do with 17.3 million dollars? The answer includes diamond rings, mansions, velvet Elvis paintings, plus a run for the border, murder-for-hire-plots, and FBI busts.
Crime Junkie
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.